CNE100001R58
CNE100001R58
WOLWO PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.062.404.471 | 925.394.525 | 14.8% |
| Cost of Revenue | 50.582.171 | 44.809.560 | 12.9% |
| Gross Profit | 1.011.822.300 | 880.584.965 | 14.9% |
| 597.411.172 | 548.019.035 | 9.0% | |
| Operating Income | 414.411.128 | 332.565.930 | 24.6% |
| Pretax Income | 432.705.375 | 365.061.773 | 18.5% |
| Net Income Common Stockholders | 380.940.984 | 317.822.382 | 19.9% |
| -- | -- | -- | |
| -- | -- | -- |